HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Gisselbrecht Selected Research

BEAM regimen

12/2014Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.
4/2011(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Gisselbrecht Research Topics

Disease

34Lymphoma (Lymphomas)
05/2019 - 02/2002
26Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 01/2002
21Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 02/2002
16Neoplasms (Cancer)
05/2022 - 06/2003
9Nausea
07/2021 - 01/2013
9Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 03/2002
8Multiple Myeloma
11/2021 - 03/2015
8B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 10/2007
8Anemia
08/2021 - 08/2009
8Thrombocytopenia (Thrombopenia)
01/2021 - 08/2009
8Hodgkin Disease (Hodgkin's Disease)
11/2020 - 06/2003
8T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 11/2004
7Disease Progression
01/2021 - 01/2008
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 11/2012
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2013 - 02/2002
6Fatigue
08/2021 - 03/2013
6Diarrhea
08/2021 - 01/2016
6Neutropenia
01/2021 - 08/2009
4Fever (Fevers)
08/2021 - 03/2015
4Pain (Aches)
08/2021 - 07/2011
4Infections
01/2021 - 09/2006
4Vomiting
11/2019 - 01/2013
3Arthralgia (Joint Pain)
08/2021 - 01/2020
3Headache (Headaches)
08/2021 - 11/2019
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2016
3Asthenia
01/2020 - 08/2009
3Lymphopenia (Lymphocytopenia)
01/2018 - 03/2013
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2015 - 04/2005
3Acquired Immunodeficiency Syndrome (AIDS)
01/2009 - 05/2006
2Cough
08/2021 - 01/2020
2Back Pain (Backache)
08/2021 - 01/2019
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 01/2008
2Myalgia
01/2020 - 03/2013
2Edema (Dropsy)
01/2020 - 03/2015
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2020
2Residual Neoplasm
01/2020 - 01/2003
2Constipation
01/2020 - 01/2019
2Febrile Neutropenia
11/2019 - 01/2016
2Drug-Related Side Effects and Adverse Reactions
11/2019 - 01/2016
2Pneumonia (Pneumonitis)
01/2018 - 03/2015
2Pathologic Complete Response
12/2014 - 06/2006
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2011 - 02/2009

Drug/Important Bio-Agent (IBA)

25Rituximab (Mabthera)FDA Link
01/2015 - 01/2002
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2002
13Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2002
13Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2002
13Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 01/2002
11Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 08/2010
9Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 08/2010
7Monoclonal AntibodiesIBA
12/2021 - 01/2002
6Etoposide (VP 16)FDA LinkGeneric
01/2021 - 09/2010
5Lenalidomide (CC 5013)FDA Link
12/2021 - 03/2015
4Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2003
4Bortezomib (Velcade)FDA Link
01/2018 - 10/2009
3Anaplastic Lymphoma KinaseIBA
01/2019 - 11/2012
3Pharmaceutical PreparationsIBA
01/2018 - 08/2003
3Brentuximab VedotinIBA
01/2018 - 04/2015
3Biological ProductsIBA
11/2017 - 05/2008
3Melphalan (Alkeran)FDA LinkGeneric
12/2014 - 01/2005
3Cisplatin (Platino)FDA LinkGeneric
11/2014 - 11/2011
3IfosfamideFDA LinkGeneric
01/2012 - 09/2010
2pomalidomideIBA
11/2021 - 03/2015
2Proteasome InhibitorsIBA
01/2021 - 01/2018
2AntigensIBA
01/2021 - 01/2002
2Chimeric Antigen ReceptorsIBA
10/2020 - 01/2020
2fms-Like Tyrosine Kinase 3IBA
01/2020 - 11/2019
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2020 - 03/2013
2Daunorubicin (Cerubidine)FDA LinkGeneric
11/2019 - 01/2019
2PanobinostatIBA
07/2018 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 11/2004
2Immunoconjugates (Immunoconjugate)IBA
04/2015 - 04/2010
2TOR Serine-Threonine KinasesIBA
01/2015 - 08/2009
2temsirolimusFDA Link
01/2015 - 08/2009
2Inotuzumab OzogamicinIBA
01/2015 - 04/2010
2ibritumomab tiuxetan (Zevalin)FDA Link
12/2014 - 04/2011
2Yttrium-90IBA
12/2014 - 04/2011
2pixantrone (BBR 2778)IBA
01/2013 - 08/2003
2IceIBA
05/2012 - 01/2012
2Carboplatin (JM8)FDA LinkGeneric
01/2012 - 11/2011
2Methotrexate (Mexate)FDA LinkGeneric
09/2010 - 05/2008
2Bleomycin (Blenoxane)FDA LinkGeneric
06/2006 - 12/2003
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2005 - 08/2003
1tafasitamabIBA
12/2021
1CD19 AntigensIBA
12/2021

Therapy/Procedure

52Therapeutics
05/2022 - 02/2002
35Stem Cell Transplantation
01/2021 - 02/2002
34Drug Therapy (Chemotherapy)
10/2021 - 01/2002
12Transplantation
05/2019 - 01/2003
6Autologous Transplantation
11/2020 - 10/2007
4Radioimmunotherapy
01/2012 - 01/2009
3Combination Drug Therapy (Combination Chemotherapy)
01/2019 - 03/2007
3Salvage Therapy
11/2011 - 12/2008
3Chemoradiotherapy
03/2007 - 04/2005
2Intravenous Infusions
01/2021 - 03/2013
2Immunotherapy
01/2020 - 01/2012
2Consolidation Chemotherapy
11/2019 - 06/2006
2Cell Transplantation
05/2019 - 11/2017
2BEAM regimen
12/2014 - 04/2011
2Aftercare (After-Treatment)
09/2006 - 02/2004
2VAP-cyclo protocol
09/2006 - 01/2002